Kira Pharmaceuticals
PrivateLast Round
Series B
Extension
Jan 7, 2021
Total Funding Raised
$71.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kira Pharmaceuticals operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B Extension round in January 2021.
Kira Pharmaceuticals is a biotechnology company that develops complement-targeted therapies to treat immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kira Pharmaceuticals Comparables
Compare Kira Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biogen | 78% | |
| Q32 Bio | 77% | |
| NovelMed Therapeutics | 77% |
For institutional investors. Book with your work email.
Kira Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2021 | ||||
| Series A | Nov 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kira Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B Extension |
| 健壹资本 | Series A |
| Foresite Capital | Series B Extension |
| 6 Dimensions Capital | Series A |
| APlus Partners | Series B Extension |
| Qiming Venture Partners | Series B Extension, Series A |
| Vivo Capital | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 195% MoM, reaching 3.4K.
- Jul 24, 2026
Monthly visitors grew 5177% MoM, from 22 to 1.2K.
For institutional investors. Book with your work email.
Kira Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kira Pharmaceuticals's valuation, stock price, and market status.
Is Kira Pharmaceuticals a public or private company?
Kira Pharmaceuticals is a private company.
What is the current stock price of Kira Pharmaceuticals?
Kira Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Kira Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kira Pharmaceuticals worth (valuation)?
Valuation information for Kira Pharmaceuticals is not publicly available.
Can I buy Kira Pharmaceuticals stock?
Kira Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kira Pharmaceuticals's last funding round?
Kira Pharmaceuticals's most recent funding round was Series B Extension on January 7, 2021.
Who are the main investors in Kira Pharmaceuticals?
Key investors in Kira Pharmaceuticals include RA Capital Management, Qiming Venture Partners, Vivo Capital, Quan Capital.
Will Kira Pharmaceuticals IPO soon?
No public IPO plans have been announced for Kira Pharmaceuticals.
How can I track Kira Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Kira Pharmaceuticals's shares on secondary markets.